These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1670 related articles for article (PubMed ID: 30351060)

  • 1. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
    Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
    ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Responsive metal-organic framework encapsulated gold nanoclusters with modulated release to enhance photodynamic therapy/chemotherapy in breast cancer.
    Zhang L; Gao Y; Sun S; Li Z; Wu A; Zeng L
    J Mater Chem B; 2020 Feb; 8(8):1739-1747. PubMed ID: 32030386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy.
    Xue T; Xu C; Wang Y; Wang Y; Tian H; Zhang Y
    Biomater Sci; 2019 Nov; 7(11):4615-4623. PubMed ID: 31441464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
    Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
    J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution.
    Abazari R; Reza Mahjoub A; Slawin AMZ; Carpenter-Warren CL
    Ultrason Sonochem; 2018 Apr; 42():594-608. PubMed ID: 29429708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Smart pH and Thermoresponsive N,O-Carboxymethyl Chitosan Conjugated Nanogels for Enhanced Therapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells.
    Verma NK; Purohit MP; Equbal D; Dhiman N; Singh A; Kar AK; Shankar J; Tehlan S; Patnaik S
    Bioconjug Chem; 2016 Nov; 27(11):2605-2619. PubMed ID: 27643823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells.
    Imanimoghadam M; Yaghoobi E; Alizadeh F; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    J Pharm Sci; 2024 Jul; 113(7):1865-1873. PubMed ID: 38342338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
    Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid)) for doxorubicin delivery in breast cancer.
    Fathi M; Alami-Milani M; Geranmayeh MH; Barar J; Erfan-Niya H; Omidi Y
    Int J Biol Macromol; 2019 May; 128():957-964. PubMed ID: 30685304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
    Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
    Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
    Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterodimers made of metal-organic frameworks and upconversion nanoparticles for bioimaging and pH-responsive dual-drug delivery.
    Ling D; Li H; Xi W; Wang Z; Bednarkiewicz A; Dibaba ST; Shi L; Sun L
    J Mater Chem B; 2020 Feb; 8(6):1316-1325. PubMed ID: 31970370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and surface modification of mesoporous metal-organic framework (UiO-66) for efficient pH-responsive drug delivery and lung cancer treatment.
    Xie C; Guo B; You H; Wang Z; Leng Q; Ding L; Wang Q
    Nanotechnology; 2021 May; 32(29):. PubMed ID: 33853047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.